Back
Citius Oncology, Inc. Stock Price Chart
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
32
CTOR
Citius Oncology, Inc.
Last Price:
$1.09
Seasonality Move:
-9.14%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTOR is experiencing selling pressure, which indicates risk of future bearish movement.
Citius Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Sell |
| 20-day SMA: | 1.14 | Sell |
| 50-day SMA: | 1.27 | Sell |
| 200-day SMA: | 1.56 | Sell |
| 8-day EMA: | 1.12 | Sell |
| 20-day EMA: | 1.15 | Sell |
| 50-day EMA: | 1.29 | Sell |
| 200-day EMA: | 1.83 | Sell |
Citius Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 44.91 | Sell |
| Chaikin Money Flow: | -118575 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.22) | Sell |
| Bollinger Bands (100): | (1.23 - 1.89) | Sell |
Citius Oncology, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Oncology, Inc. Stock
Is Citius Oncology, Inc. Stock a Buy?
-
Citius Oncology, Inc. share price is 1.09 while CTOR 8-day simple moving average is 1.10, which is a Sell signal.
-
The stock price of CTOR is 1.09 while Citius Oncology, Inc. 20-day SMA is 1.14, which makes it a Sell.
-
Citius Oncology, Inc. 50-day simple moving average is 1.27 while CTOR share price is 1.09, making it a Sell technically.
-
CTOR stock price is 1.09 and Citius Oncology, Inc. 200-day simple moving average is 1.56, creating a Sell signal.
CTOR Technical Analysis vs Fundamental Analysis
Sell
32
Citius Oncology, Inc. (CTOR)
is a Sell
Is Citius Oncology, Inc. a Buy or a Sell?
-
Citius Oncology, Inc. stock is rated a SellThe current Citius Oncology, Inc. [CTOR] share price is $1.09. The Score for CTOR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Citius Oncology, Inc. Stock Info
Market Cap:
92.4M
Price in USD:
1.09
Share Volume:
177.9K
Citius Oncology, Inc. 52-Week Range
52-Week High:
6.19
52-Week Low:
0.55
Sell
32
Citius Oncology, Inc. (CTOR)
is a Sell
Citius Oncology, Inc. Share Price Forecast
-
What is the Citius Oncology, Inc. stock price today?The Citius Oncology, Inc. stock price is 1.09 USD today.
-
Will CTOR stock go up or go down?Citius Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology, Inc. is overvalued.
Is Citius Oncology, Inc. Stock a Buy?
-
Citius Oncology, Inc. share price is 1.09 while CTOR 8-day exponential moving average is 1.12, which is a Sell signal.
-
The stock price of CTOR is 1.09 while Citius Oncology, Inc. 20-day EMA is 1.15, which makes it a Sell.
-
Citius Oncology, Inc. 50-day exponential moving average is 1.29 while CTOR share price is 1.09, making it a Sell technically.
-
CTOR stock price is 1.09 and Citius Oncology, Inc. 200-day simple moving average is 1.83, creating a Sell signal.
Technical Analysis of Citius Oncology, Inc.
Should I short Citius Oncology, Inc. stock?
-
CTOR Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Citius Oncology, Inc. is a Sell
-
Citius Oncology, Inc. Relative Strength Index (RSI) is 44.91, which suggest Citius Oncology, Inc. is oversold
-
The Bollinger Bands (25) for Citius Oncology, Inc. is (1.06 - 1.22), which suggest Citius Oncology, Inc. is a Sell
-
The Bollinger Bands (100) for Citius Oncology, Inc. is (1.23 - 1.89), which suggest Citius Oncology, Inc. is a Sell
* Citius Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.